PP13, maternal ABO blood groups and the risk assessment of pregnancy complications

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Than, Nandor Gabor ^a,b   Romero, Roberto ^b   Meiri, Hamutal ^c,d   Erez, Offer ^b,e   Xu, Yi ^b   Tarquini, Federica ^b   Barna, Laszlo ^f   Szilagyi, Andras ^f   Ackerman, Ron ^c   Sammar, Marei ^c,g   Fule, Tibor ^h   Karaszi, Katalin ^a,h   Kovalszky, Ilona ^h   Dong, Zhong ^b   Kim, Chong Jai ^b   Zavodszky, Peter ^f   Papp, Zoltan ^a   Gonen, Ron ⁱ  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b WAYNE STATE UNIVERSITY   (United States)

^c Diagnostic Technologies Ltd   (Israel)

^d TeleMarpeh Ltd   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f INSTITUTE OF ENZYMOLOGY   (Hungary)

^g ORT BRAUDE COLLEGE   (Israel)

^h SEMMELWEIS UNIVERSITY   (Hungary)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP H ANTIGEN; PLACENTA PROTEIN; PLACENTA PROTEIN 13; UNCLASSIFIED DRUG; GALECTIN; LGALS13 PROTEIN, HUMAN;

ANTIGEN BINDING; ARTICLE; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; CAUCASIAN; COMPLEX FORMATION; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHROCYTE; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HISPANIC; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MOLECULAR MODEL; PLACENTA; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANT WOMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; AMINO ACID SEQUENCE; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; MOLECULAR GENETICS; MOTHER; PREGNANCY; PREGNANCY COMPLICATION; PROTEIN CONFORMATION;

ABO BLOOD-GROUP SYSTEM; AMINO ACID SEQUENCE; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FETAL GROWTH RETARDATION; GALECTINS; HISPANIC AMERICANS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOTHERS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY PROTEINS; PROTEIN CONFORMATION; RISK ASSESSMENT; SUBSTRATE SPECIFICITY;

EID: 79960701081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021564     Document Type: Article

References (68)

1. Varki A, Cummings R, Esko JD, Freeze H, Stanley P, et al. (2008) Essentials in Glycobiology New York Cold Spring Harbor Laboratory Press.
2. Watkins WM, (2001) The ABO blood group system: historical background. Transfus Med 11: 243-265.
3. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, et al. (2001) ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83: 565-573.
4. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR, (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69: 1691-1695.
5. O'Donnell J, Laffan MA, (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11: 343-351.
6. Medalie JH, Levene C, Papier C, Goldbourt U, Dreyfuss F, et al. (1971) Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med 285: 1348-1353.
7. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, et al. (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 88: 601-607.
8. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR, (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345: 152-155.
9. Larsen TB, Johnsen SP, Gislum M, Moller CA, Larsen H, et al. (2005) ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 3: 300-304.
10. Reid ME, Bird GW, (1990) Associations between human red cell blood group antigens and disease. Transfus Med Rev 4: 47-55.
11. Sibai B, Dekker G, Kupferminc M, (2005) Pre-eclampsia. Lancet 365: 785-799.
12. Redman CW, Sargent IL, (2010) Immunology of pre-eclampsia. Am J Reprod Immunol 63: 534-543.
13. Spinillo A, Capuzzo E, Egbe TO, Nicola S, Piazzi G, et al. (1994) Cigarette smoking in pregnancy and risk of pre-eclampsia. J Hum Hypertens 8: 771-775.
14. Spinillo A, Capuzzo E, Baltaro F, Piazzi G, Iasci A, (1995) Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 9: 623-625.
15. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, et al. (2009) Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study. Thromb Res 124: 167-173.
16. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, et al. (2006) A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 27: 13-17.
17. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, et al. (2007) First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 197: 35-37.
18. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H, (2007) First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 29: 128-134.
19. Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, et al. (2008) First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 199: 122.
20. Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, et al. (2008) Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 24: 230-236.
21. Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, et al. (2008) Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG 115: 1465-1472.
22. Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, et al. (2009) First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 29: 781-789.
23. Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, et al. (2010) First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol 35: 671-679.
24. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH, (2009) Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn 29: 1103-1108.
25. Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, et al. (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 117: 1384-1389.
26. Cowans NJ, Stamatopoulou A, Khalil A, Spencer K, (2011) PP13 as a marker of pre-eclampsia: A two platform comparison study. Placenta 32 (Suppl:S37-41): S37-S41.
27. Visegrady B, Than NG, Kilar F, Sumegi B, Than GN, et al. (2001) Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng 14: 875-880.
28. Than NG, Pick E, Bellyei S, Szigeti A, Burger O, et al. (2004) Functional analyses of placental protein 13/galectin-13. Eur J Biochem 271: 1065-1078.
29. Than NG, Romero R, Goodman M, Weckle A, Xing J, et al. (2009) A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci U S A 106: 9731-9736.
30. Bohn H, Kraus W, Winckler W, (1983) Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17). Oncodev Biol Med 4: 343-350.
31. Than NG, Sumegi B, Than GN, Berente Z, Bohn H, (1999) Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein. Placenta 20: 703-710.
32. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, et al. (2004) Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 25: 608-622.
33. Than NG, Abdul RO, Magenheim R, Nagy B, Fule T, et al. (2008) Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch 453: 387-400.
34. Balogh A, Pozsgay J, Matko J, Dong Z, Kim CJ, et al. (2011) Placental Protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2011 Mar 22. [Epub ahead of print], doi: 10.1016/j.ajog.2011.03.023.
35. Sekizawa A, Purwosunu Y, Yoshimura S, Nakamura M, Shimizu H, et al. (2009) PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod Sci 16: 408-413.
36. Shimizu H, Sekizawa A, Purwosunu Y, Nakamura M, Farina A, et al. (2009) PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. Prenat Diagn 29: 1231-1236.
37. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, et al. (2008) Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283: 10109-10123.
38. Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine JP, et al. (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16: 295-301.
39. Horlacher T, Oberli MA, Werz DB, Krock L, Bufali S, et al. (2010) Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. Chembiochem 11: 1563-1573.
40. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM, (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV.
41. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183: S1-S22.
42. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M, (1996) A United States national reference for fetal growth. Obstet Gynecol 87: 163-168.
43. Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES, (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7: 311-314.
44. Papp Cs, Szabo G, Toth-Pal E, Papp Z, (1991) Fetal growth rate and its variations 1988/89. Orv Hetil 132: 1865-1870.
45. Varkonyi T, Nagy B, Fule T, Tarca AL, Karaszi K, et al. (2011) Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 32 (Suppl): S21-S29.
46. Walser PJ, Haebel PW, Kunzler M, Sargent D, Kues U, et al. (2004) Structure and functional analysis of the fungal galectin CGL2. Structure 12: 689-702.
47. Sharon R, Fibach E, (1991) Quantitative flow cytometric analysis of ABO red cell antigens. Cytometry 12: 545-549.
48. Bratosin D, Mazurier J, Debray H, Lecocq M, Boilly B, et al. (1995) Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life span. Glycoconj J 12: 258-267.
49. Gabius HJ, Andre S, Kaltner H, Siebert HC, (2002) The sugar code: functional lectinomics. Biochim Biophys Acta 1572: 165-177.
50. Buzas EI, Gyorgy B, Pasztoi M, Jelinek I, Falus A, et al. (2006) Carbohydrate recognition systems in autoimmunity. Autoimmunity 39: 691-704.
51. Yamamoto F, Clausen H, White T, Marken J, Hakomori S, (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345: 229-233.
52. Cohen M, Hurtado-Ziola N, Varki A, (2009) ABO blood group glycans modulate sialic acid recognition on erythrocytes. Blood 114: 3668-3676.
53. Lenting PJ, Pegon JN, Christophe OD, Denis CV, (2010) Factor VIII and von Willebrand factor-too sweet for their own good. Haemophilia 16 (Suppl 5:194-9): 194-199.
54. Romero R, (1996) Prenatal medicine: the child is the father of the man. Prenatal and Neonatal Medicine 1: 8-11.
55. Lin J, August P, (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105: 182-192.
56. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340: 9-13.
57. Roberts JM, Hubel CA, (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30 (Suppl A): S32-S37.
58. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS, (2009) Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30 (Suppl A): S43-S48.
59. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, et al. (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 29: 1958-1967.
60. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ, (2002) Does endothelial cell activation occur with intrauterine growth restriction? BJOG 109: 836-839.
61. Liu FT, Rabinovich GA, (2010) Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci 1183: 158-182.
62. Than GN, Bohn H, Szabo DG, (1993) Advances in pregnancy-related protein research Boca Raton CRC Press.
63. Mayhew TM, Wadrop E, Simpson RA, (1994) Proliferative versus hypertrophic growth in tissue subcompartments of human placental villi during gestation. J Anat 184 (Pt 3): 535-543.
64. Kliman HJ, Sammar M, Lynch S, Grimpel Y, Pick E, et al. (2008) PP13 (galectin-13) mediated zones of necrosis diverts the maternal immune response away from the decidual spiral arterioles. Hypertension in Pregnancy 27: 578.
65. Brewer CF, Miceli MC, Baum LG, (2002) Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol 12: 616-623.
66. Cummings RD, Liu FT, (2009) Galectins. In: Varki A, Cummings R, Esko JD, Freeze H, Stanley P, editors. Essentials of Glycobiology pp. 475-488 Cold Spring Harbor Laboratory Press; Cold Spring Harbor (NY).
67. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, et al. (2007) A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13: 1450-1457.
68. Than NG, Romero R, Erez O, Weckle A, Tarca AL, et al. (2008) Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc Natl Acad Sci U S A 105: 15819-15824.